Downregulation of L1CAM inhibits proliferation, invasion and arrests cell cycle progression in pancreatic cancer cells in vitro

Ben,Qiwen; An,Wei; Fei,Jian; Xu,Maojin; Li,Guixiang; Li,Zhaoshen; Yuan,Yaozong

doi:10.3892/etm.2014.1519

Downregulation of L1CAM inhibits proliferation, invasion and arrests cell cycle progression in pancreatic cancer cells in vitro

Authors:
- Qiwen Ben
- Wei An
- Jian Fei
- Maojin Xu
- Guixiang Li
- Zhaoshen Li
- Yaozong Yuan
View Affiliations

Affiliations: Department of Gastroenterology, Ruijin Hospital, Shanghai Jiaotong University, Shanghai, P.R. China, Department of Gastroenterology, Changhai Hospital of Second Military Medical University, Shanghai, P.R. China, Department of General Surgery, Ruijin Hospital, Shanghai Jiaotong University, Shanghai, P.R. China, Department of Endocrinology, Changhai Hospital of Second Military Medical University, Shanghai, P.R. China
Published online on: February 5, 2014 https://doi.org/10.3892/etm.2014.1519
Pages: 785-790

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to establish the effect of silencing L1 cell adhesion molecule (L1CAM) on the proliferation, invasion, cell cycle progression and apoptosis of pancreatic cancer cells, and to determine the potential molecular mechanisms that are involved. The human Capan‑2 pancreatic cancer cell line was infected with lentivirus‑mediated short hairpin RNA (shRNA) to target L1CAM. Cell proliferation and invasion were analyzed using cell counting kit‑8 and Transwell assays, respectively, and cell cycle progression and apoptosis were analyzed using flow cytometry. L1CAM protein expression in Capan‑2 cells decreased following shRNA‑L1CAM infection. Furthermore, knockdown of L1CAM significantly inhibited cell proliferation and reduced the number of invasive cells, while increasing the percentage of cells in the G0/G1 phase (P<0.05). However, the effect on apoptosis was not identified to be statistically significant. In addition, L1CAM silencing may induce activation of p38/extracellular signal regulated kinase 1/2. Downregulation of L1CAM may inhibit proliferation, invasion and arrests cell cycle progression in pancreatic cancer via p38/ERK1/2 signal pathway, and therefore, L1CAM may serve as a potential target for gene therapy in pancreatic cancer.

View Figures

View References

1	Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66. 2007. View Article : Google Scholar
2	Neoptolemos JP, Stocken DD, Friess H, et al; European Study Group for Pancreatic Cancer. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 350:1200–1210. 2004. View Article : Google Scholar : PubMed/NCBI
3	Guo X and Cui Z: Current diagnosis and treatment of pancreatic cancer in China. Pancreas. 31:13–22. 2005. View Article : Google Scholar : PubMed/NCBI
4	Schneider G, Siveke JT, Eckel F and Schmid RM: Pancreatic cancer: basic and clinical aspects. Gastroenterology. 128:1606–1625. 2005. View Article : Google Scholar : PubMed/NCBI
5	Fransen E, Lemmon V, Van Camp G, Vits L, Coucke P and Willems PJ: CRASH syndrome: clinical spectrum of corpus callosum hypoplasia, retardation, adducted thumbs, spastic paraparesis and hydrocephalus due to mutations in one single gene, L1. Eur J Hum Genet. 3:273–284. 1995.PubMed/NCBI
6	Kajiwara Y, Ueno H, Hashiguchi Y, et al: Expression of l1 cell adhesion molecule and morphologic features at the invasive front of colorectal cancer. Am J Clin Pathol. 136:138–144. 2011. View Article : Google Scholar : PubMed/NCBI
7	Schäfer H, Dieckmann C, Korniienko O, et al: Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma. Cancer Lett. 319:66–82. 2012.PubMed/NCBI
8	Bao S, Wu Q, Li Z, et al: Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res. 68:6043–6048. 2008. View Article : Google Scholar : PubMed/NCBI
9	Hai J, Zhu CQ, Bandarchi B, et al: L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer. Clin Cancer Res. 18:1914–1924. 2012. View Article : Google Scholar : PubMed/NCBI
10	Li S, Jo YS, Lee JH, et al: L1 cell adhesion molecule is a novel independent poor prognostic factor of extrahepatic cholangiocarcinoma. Clin Cancer Res. 15:7345–7351. 2009. View Article : Google Scholar : PubMed/NCBI
11	Ben QW, Wang JC, Liu J, et al: Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma. Ann Surg Oncol. 17:2213–2221. 2010. View Article : Google Scholar : PubMed/NCBI
12	Issa Y, Nummer D, Seibel T, et al: Enhanced L1CAM expression on pancreatic tumor endothelium mediates selective tumor cell transmigration. J Mol Med (Berl). 87:99–112. 2009. View Article : Google Scholar : PubMed/NCBI
13	Silletti S, Yebra M, Perez B, Cirulli V, McMahon M and Montgomery AM: Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion. J Biol Chem. 279:28880–28888. 2004. View Article : Google Scholar : PubMed/NCBI
14	Elbashir SM, Harborth J, Weber K and Tuschl T: Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods. 26:199–213. 2002. View Article : Google Scholar : PubMed/NCBI
15	Zecchini S, Bianchi M, Colombo N, et al: The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium. Cancer Res. 68:1110–1118. 2008. View Article : Google Scholar : PubMed/NCBI
16	Gast D, Riedle S, Riedle S, et al: L1 augments cell migration and tumor growth but not beta3 integrin expression in ovarian carcinomas. Int J Cancer. 115:658–665. 2005. View Article : Google Scholar : PubMed/NCBI
17	Gavert N, Conacci-Sorrell M, Gast D, et al: L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol. 168:633–642. 2005. View Article : Google Scholar : PubMed/NCBI
18	Arlt MJ, Novak-Hofer I, Gast D, et al: Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment. Cancer Res. 66:936–943. 2006. View Article : Google Scholar
19	Kiefel H, Bondong S, Erbe-Hoffmann N, et al: L1CAM-integrin interaction induces constitutive NF-kappaB activation in pancreatic adenocarcinoma cells by enhancing IL-1beta expression. Oncogene. 29:4766–4778. 2010. View Article : Google Scholar : PubMed/NCBI
20	Bondong S, Kiefel H, Hielscher T, et al: Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation. Ann Oncol. 23:1795–1802. 2012.PubMed/NCBI
21	Izumoto S and Yoshimine T: Role of neural cell adhesion molecule L1 in glioma invasion. Nihon Rinsho. 63(Suppl 9): 74–78. 2005.(In Japanese).
22	Voura EB, Ramjeesingh RA, Montgomery AM and Siu CH: Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells. Mol Biol Cell. 12:2699–2710. 2001. View Article : Google Scholar : PubMed/NCBI
23	Min JK, Kim JM, Li S, et al: L1 cell adhesion molecule is a novel therapeutic target in intrahepatic cholangiocarcinoma. Clin Cancer Res. 16:3571–3580. 2010. View Article : Google Scholar : PubMed/NCBI
24	Gavert N, Ben-Shmuel A, Lemmon V, Brabletz T and Ben-Ze’ev A: Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells. J Cell Sci. 123:2135–2143. 2010. View Article : Google Scholar : PubMed/NCBI
25	Mechtersheimer S, Gutwein P, Agmon-Levin N, et al: Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. J Cell Biol. 155:661–673. 2001. View Article : Google Scholar : PubMed/NCBI
26	Gavert N, Sheffer M, Raveh S, et al: Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. Cancer Res. 67:7703–7712. 2007. View Article : Google Scholar : PubMed/NCBI
27	Sebens Müerköster S, Werbing V, Sipos B, et al: Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene. 26:2759–2768. 2007.PubMed/NCBI
28	Boo YJ, Park JM, Kim J, et al: L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer. Ann Surg Oncol. 14:1703–1711. 2007. View Article : Google Scholar : PubMed/NCBI
29	Kodera Y, Nakanishi H, Ito S, et al: Expression of L1 cell adhesion molecule is a significant prognostic factor in pT3-stage gastric cancer. Anticancer Res. 29:4033–4039. 2009.PubMed/NCBI
30	Rawnaq T, Kleinhans H, Uto M, et al: Subset of esophageal adenocarcinoma expresses adhesion molecule l1 in contrast to squamous cell carcinoma. Anticancer Res. 29:1195–1199. 2009.PubMed/NCBI
31	Schröder C, Schumacher U, Fogel M, et al: Expression and prognostic value of L1-CAM in breast cancer. Oncol Rep. 22:1109–1117. 2009.PubMed/NCBI
32	Schaefer AW, Kamiguchi H, Wong EV, Beach CM, Landreth G and Lemmon V: Activation of the MAPK signal cascade by the neural cell adhesion molecule L1 requires L1 internalization. J Biol Chem. 274:37965–37973. 1999. View Article : Google Scholar : PubMed/NCBI
33	Gast D, Riedle S, Issa Y, et al: The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies. Oncogene. 27:1281–1289. 2008. View Article : Google Scholar : PubMed/NCBI
34	Cheng L, Lemmon S and Lemmon V: RanBPM is an L1-interacting protein that regulates L1-mediated mitogen-activated protein kinase activation. J Neurochem. 94:1102–1110. 2005. View Article : Google Scholar : PubMed/NCBI
35	Kiefel H, Bondong S, Pfeifer M, et al: EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-κB activation. Carcinogenesis. 33:1919–1929. 2012.PubMed/NCBI
36	Shtutman M, Levina E, Ohouo P, Baig M and Roninson IB: Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells. Cancer Res. 66:11370–11380. 2006. View Article : Google Scholar : PubMed/NCBI
37	Huszar M, Pfeifer M, Schirmer U, et al: Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas. J Pathol. 220:551–561. 2010. View Article : Google Scholar : PubMed/NCBI
38	Tischler V, Pfeifer M, Hausladen S, et al: L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer. Mol Cancer. 10:1272011. View Article : Google Scholar : PubMed/NCBI
39	Geismann C, Morscheck M, Koch D, et al: Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer. Cancer Res. 69:4517–4526. 2009. View Article : Google Scholar : PubMed/NCBI
40	Gavert N, Vivanti A, Hazin J, Brabletz T and Ben-Ze’ev A: L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers. Mol Cancer Res. 9:14–24. 2011. View Article : Google Scholar : PubMed/NCBI